| http://www.w3.org/ns/prov#value | - Appropriate laboratory testing should be conducted prior to initiating therapy with darunavir/rtv and patients' liver enzymes should be monitored during treatment.If new or worsening liver dysfunction (including significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, or hepatomegaly) develops in patients using darunavir/rtv,
|
